STOK icon

Stoke Therapeutics
STOK

Upgrade to unlock
Buy
Hold
Sell

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$32
4% downside
High target

5 analyst ratings

positive
1  neutral
20%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Canaccord Genuity
Canaccord Genuity
Sumant Kulkarni
100% 1-yr STOK win rate
5 Nov ‘25 1 month ago
Wedbush
Wedbush
Laura Chico
100% 1-yr STOK win rate
5 Nov ‘25 1 month ago
BTIG
BTIG
Thomas Shrader
50% 1-yr STOK win rate
5 Nov ‘25 1 month ago
JP Morgan
JP Morgan
Jessica Fye
3 Nov ‘25 1 month ago
Needham
Needham
Joseph Stringer
67% 1-yr STOK win rate
10 Oct ‘25 2 months ago